Google DeepMind
Search results
We’re a digital biology company, here to redefine drug discovery with the power of artificial intelligence. 2. a--up. a--h-150-100. 0. a--up. none. We believe there’s a fundamental symmetry in the universe between biology and information science.
1. a--up. none. Isomorphic Labs was born in 2021 to apply AI and computational methods to drug discovery, and transform the way medicine helps and heals people. We’re building on the AlphaFold breakthrough in active partnership with Google DeepMind, united together as members of the Alphabet family. And that makes us different.
Isomorphic Labs Limited is a London-based company which uses artificial intelligence for drug discovery. [2] [3] [4] Isomorphic Labs was founded by Demis Hassabis , who also serves the CEO. [5] [3] The company was incorporated on February 4, 2021 and announced on November 5, 2021.
Now the time is right to push this forward at pace, and with the dedicated focus and resources that Isomorphic Labs will bring. An AI-first approach to drug discovery and biology The pandemic has brought to the fore the vital work that brilliant scientists and clinicians do every day to understand and combat disease.
May 8, 2024 · Introducing AlphaFold 3, a new AI model developed by Google DeepMind and Isomorphic Labs. By accurately predicting the structure of proteins, DNA, RNA, ligands and more, and how they interact, we hope it will transform our understanding of the biological world and drug discovery. G. Google DeepMind AlphaFold team. I.
Nov 4, 2021 · Google parent company Alphabet is launching a new company called Isomorphic Laboratories which will use AI tools for drug discovery. It will build off the protein folding work from DeepMind.
